PROLONGED INFUSION OF HEXAMETHYLENE BISACETAMIDE (HMBA) - PHASE-I AND PHARMACOLOGICAL STUDY

被引：0
|
作者：
MCGUIRE, WP [1 ]
ROWINSKY, EK [1 ]
ETTINGER, DS [1 ]
GROCHOW, LB [1 ]
LUK, GD [1 ]
DONEHOWER, RC [1 ]
机构：
[1] JOHNS HOPKINS UNIV HOSP,CTR ONCOL,BALTIMORE,MD 21205
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1987年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [1] PROLONGED INFUSION OF HEXAMETHYLENE BISACETAMIDE - A PHASE-I AND PHARMACOLOGICAL STUDY
    ROWINSKY, EK
    ETTINGER, DS
    MCGUIRE, WP
    NOE, DA
    GROCHOW, LB
    DONEHOWER, RC
    CANCER RESEARCH, 1987, 47 (21) : 5788 - 5795
  • [2] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF HEXAMETHYLENE BISACETAMIDE (HMBA) BY 10 DAY CONTINUOUS INFUSION (CI)
    WALSH, TD
    FANUCCHI, MP
    WILLIAMS, L
    LOKOS, G
    STEVENS, YW
    CASSIDY, C
    YOUNG, CW
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 188 - 188
  • [3] PHASE-I AND PHARMACOLOGICAL STUDY OF HEXAMETHYLENE BISACETAMIDE IN PATIENTS WITH ADVANCED CANCER
    ROWINSKY, EK
    ETTINGER, DS
    GROCHOW, LB
    BRUNDRETT, RB
    CATES, AE
    DONEHOWER, RC
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (12) : 1835 - 1844
  • [4] PHASE-I BIOAVAILABILITY AND PHARMACOKINETICS OF ORAL HEXAMETHYLENE BISACETAMIDE (HMBA, NSC-95580)
    CHUN, HG
    ROTH, JS
    KELLEY, JA
    WARD, FT
    WEISS, RB
    BALASUBRAMANIAM, S
    LOMBARDO, FA
    LEYLANDJONES, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 191 - 191
  • [5] PHASE-I AND PHARMACOLOGICAL STUDY OF VINBLASTINE BY PROLONGED CONTINUOUS INFUSION
    RATAIN, MJ
    VOGELZANG, NJ
    CANCER RESEARCH, 1986, 46 (09) : 4827 - 4830
  • [6] PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF HEXAMETHYLENE BISACETAMIDE (NSC-95580) ADMINISTERED AS A 5-DAY CONTINUOUS INFUSION
    EGORIN, MJ
    SIGMAN, LM
    VANECHO, DA
    FORREST, A
    WHITACRE, MY
    AISNER, J
    CANCER RESEARCH, 1987, 47 (02) : 617 - 623
  • [7] PHASE-I AND CLINICAL PHARMACOLOGICAL STUDY OF MERCAPTOPURINE ADMINISTERED AS A PROLONGED INTRAVENOUS-INFUSION
    ZIMM, S
    ETTINGER, LJ
    HOLCENBERG, JS
    KAMEN, BA
    VIETTI, TJ
    BELASCO, J
    COGLIANOSHUTTA, N
    BALIS, F
    LAVI, LE
    COLLINS, JM
    POPLACK, DG
    CANCER RESEARCH, 1985, 45 (04) : 1869 - 1873
  • [8] PHASE-I TRIAL AND CLINICAL PHARMACOLOGICAL EVALUATION OF HEXAMETHYLENE BISACETAMIDE ADMINISTRATION BY 10-DAY CONTINUOUS INTRAVENOUS-INFUSION AT 28-DAY INTERVALS
    YOUNG, CW
    FANUCCHI, MP
    WALSH, TD
    BALTZER, L
    YALDAEI, S
    STEVENS, YW
    GORDON, C
    TONG, W
    RIFKIND, RA
    MARKS, PA
    CANCER RESEARCH, 1988, 48 (24) : 7304 - 7309
  • [9] A PHASE-I BIOAVAILABILITY AND PHARMACOKINETIC STUDY OF HEXAMETHYLENE BISACETAMIDE (NSC-95580) ADMINISTERED VIA NASOGASTRIC TUBE
    WARD, FT
    KELLEY, JA
    ROTH, JS
    LOMBARDO, FA
    WEISS, RB
    LEYLANDJONES, B
    CHUN, HG
    CANCER RESEARCH, 1991, 51 (07) : 1803 - 1810
  • [10] PHASE-I TRIAL USING ADAPTIVE-CONTROL DOSING OF HEXAMETHYLENE BISACETAMIDE (NSC-95580)
    CONLEY, BA
    FORREST, A
    EGORIN, MJ
    ZUHOWSKI, EG
    SINIBALDI, V
    VANECHO, DA
    CANCER RESEARCH, 1989, 49 (12) : 3436 - 3440
12345